| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing precisely levofloxacin 250 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Levofloxacin 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Levofloxacin 5mg/mL infusion solution 100mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Levofloxacin 750 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Levofloxacin 25mg/mL injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Levofloxacin 25mg/mL injection 30mL vial (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Levofloxacin 25mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Levofloxacin 5mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Levofloxacin 5mg solution (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing levofloxacin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing levofloxacin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing levofloxacin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Levofloxacin 5mg/mL intravenous injection solution 150mL premixed bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Levofloxacin 5mg/mL intravenous injection solution 100mL premixed bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Levofloxacin 5mg/mL intravenous injection solution 50mL premixed bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Levofloxacin 1.5% ophthalmic solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Levofloxacin 25mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing levofloxacin in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Allergy to levofloxacin |
Causative agent (attribute) |
False |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Levofloxacin hemihydrate (substance) |
Is a |
False |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely levofloxacin 250 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely levofloxacin 250 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
True |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Levofloxacin 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Levofloxacin 500 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Levofloxacin 750 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Levofloxacin 750 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Levofloxacin 750 mg oral tablet |
Has precise active ingredient |
True |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely levofloxacin 250 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
True |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Levofloxacin 500 mg oral tablet |
Has precise active ingredient |
True |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Levofloxacin hemihydrate (substance) |
Is modification of (attribute) |
True |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely levofloxacin (as levofloxacin hemihydrate) 500 milligram/100 milliliter conventional release solution for infusion vial |
Has basis of strength substance (attribute) |
False |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing levofloxacin in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Levofloxacin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Allergy to levofloxacin |
Causative agent (attribute) |
True |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Levofloxacin only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only levofloxacin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only levofloxacin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely levofloxacin (as levofloxacin hemihydrate) 5 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
Has basis of strength substance (attribute) |
False |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely levofloxacin (as levofloxacin hemihydrate) 250 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Levofloxacin anhydrous |
Is modification of (attribute) |
True |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely levofloxacin anhydrous (as levofloxacin) 15 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has precise active ingredient |
True |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Levofloxacin anhydrous (as levofloxacin) 5 mg/mL eye solution |
Has precise active ingredient |
True |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Levofloxacin anhydrous (as levofloxacin) 25 mg/mL oral solution |
Has precise active ingredient |
True |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Levofloxacin 5 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Levofloxacin 5 mg/mL solution for injection |
Has precise active ingredient |
True |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Levofloxacin 5 mg/mL solution for infusion |
Has precise active ingredient |
True |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Levofloxacin 5 mg/mL solution for infusion |
Has basis of strength substance (attribute) |
True |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely levofloxacin 100 milligram/1 each tablet for conventional release oral suspension (clinical drug) |
Has precise active ingredient |
True |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely levofloxacin 100 milligram/1 each tablet for conventional release oral suspension (clinical drug) |
Has basis of strength substance (attribute) |
True |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely levofloxacin 5 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
Has precise active ingredient |
True |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely levofloxacin 5 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing dexamethasone and levofloxacin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only dexamethasone and levofloxacin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Dexamethasone- and levofloxacin-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Dexamethasone and levofloxacin only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely dexamethasone (as dexamethasone sodium phosphate) 1 milligram/1 milliliter and levofloxacin 5 milligram/1 milliliter conventional release solution for eye drops (clinical drug) |
Has precise active ingredient |
True |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely dexamethasone (as dexamethasone sodium phosphate) 1 milligram/1 milliliter and levofloxacin 5 milligram/1 milliliter conventional release solution for eye drops (clinical drug) |
Has basis of strength substance (attribute) |
True |
Levofloxacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]